What is the company's current financial performance, and is it profitable?

Intuitive Surgical is currently not profitable. For the first quarter ended March 31, 2002, the company reported a net loss of $5.6 million, an increase from a net loss of $3.4 million in the same period last year. While sales are growing, operating expenses are also increasing, leading to a wider net loss.

What is driving the company's sales growth?

Sales growth is primarily driven by an increase in recurring revenue from instruments, accessories, and service contracts, which more than doubled year-over-year. The company also saw a slight increase in the number of da Vinci Surgical System placements.

How is the company managing its cash flow, and what are its liquidity prospects?

The company used $7.0 million in net cash from operating activities in the first quarter of 2002, indicating it is still consuming cash. However, it has substantial cash and short-term investments. Management believes current resources will fund operations through at least 2003, but acknowledges the potential need for additional financing thereafter, which could result in stock dilution.

What are the main risks and challenges facing Intuitive Surgical?

Key risks include the long and uncertain sales cycle for its high-value capital equipment, intense competition, ongoing intellectual property litigation with competitors like Computer Motion and Brookhill-Wilk 1, the need to gain broad market acceptance for its novel surgical technology, and regulatory hurdles. The company also faces risks related to manufacturing scalability and reliance on third-party suppliers.

ISRG 10-Q Quarterly Report Q1 FY2002 — Revenue, Net Income, EPS

Summary

Intuitive Surgical, Inc. (ISRG) reported its financial results for the first quarter ended March 31, 2002. The company continues to operate at a loss, with a net loss of $5.6 million for the quarter, an increase from the $3.4 million net loss in the prior year's first quarter. However, sales showed positive growth, reaching $14.4 million, a 19% increase compared to $12.1 million in the first quarter of 2001. This growth was driven by a significant increase in recurring revenue (instruments, accessories, and service), which more than doubled year-over-year, alongside a modest increase in da Vinci Surgical System placements. Despite the growing revenue, operating costs and expenses also increased, leading to a widening loss from operations. The company's cash position remains substantial, supported by its investments, but it continues to be a cash-intensive business, utilizing $7.0 million in operating activities during the quarter. Management expects to continue making substantial investments in research and development and anticipates increased selling, general, and administrative expenses to support business expansion. The company believes its current cash and short-term investments will be sufficient to fund operations through at least 2003, but may require additional financing thereafter.

Key Highlights

1Sales increased by 19% to $14.4 million in Q1 2002 from $12.1 million in Q1 2001.
2Recurring revenue (instruments, accessories, and service) surged by 120% to $2.7 million in Q1 2002 from $1.2 million in Q1 2001.
3The company shipped 13 da Vinci Surgical Systems in Q1 2002, compared to 12 in Q1 2001, bringing the cumulative total to 102 systems.
4Gross profit margin improved to 48% in Q1 2002 from 46% in Q1 2001 due to sales growth and manufacturing efficiencies.
5Research and Development expenses increased by 31% to $4.2 million, reflecting continued investment in product development.
6Selling, General, and Administrative expenses rose by 29% to $8.8 million, supporting increased revenue and installed base.
7Net loss widened to $5.6 million ($0.15 per share) in Q1 2002 from $3.4 million ($0.10 per share) in Q1 2001.

INTUITIVE SURGICAL INC Quarterly Report for Q1 Ended Mar 31, 2002

Summary

Key Highlights

Frequently Asked Questions